Literature DB >> 14694423

Comparison of oxidative stress induced by ciprofloxacin and pyoverdin in bacteria and in leukocytes to evaluate toxicity.

M C Becerra1, A J Eraso, I Albesa.   

Abstract

Oxidative stress induced by ciprofloxacin and pyoverdin, a leukotoxic pigment, was studied by comparing their effect in bacteria and leukocytes. Chemiluminescence (CL) assays with lucigenin or luminol were adapted to measure the stimuli of superoxide anion (O2 -) and other reactive species of oxygen (ROS) in bacteria. Ciprofloxacin principally induced the production of O2 - in the three species studied: Staphylococcus aureus, Enterococcus faecalis and Escherichia coli. Lucigenin CL assay showed high oxidative stress in S. aureus due to its low superoxide dismutase (SOD) activity, whereas E. coli exhibited important SOD activity, responsible for little production of O2 - in absence or presence of ciprofloxacin. Reduction of nitroblue of tetrazolium (NBT) was applied. This assay indicated that there was higher oxidative stress in S. aureus and E. faecalis than in E. coli. The comparison of oxidative stress generated in bacteria and leukocytes was used to check the selective toxicity of ciprofloxacin in comparison with pyoverdin. Ciprofloxacin did not generate significant stimuli of O2 - in neutrophils, while pyoverdin duplicated the production of O2 -. CL and NBT were useful to study the leukotoxicity of ciprofloxacin. Oxidative stress caused by the antibiotic and the leukotoxic pigment was similar in bacteria. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14694423     DOI: 10.1002/bio.742

Source DB:  PubMed          Journal:  Luminescence        ISSN: 1522-7235            Impact factor:   2.464


  7 in total

1.  Lipids and DNA oxidation in Staphylococcus aureus as a consequence of oxidative stress generated by ciprofloxacin.

Authors:  María Cecilia Becerra; Paulina Laura Páez; Laura E Laróvere; Inés Albesa
Journal:  Mol Cell Biochem       Date:  2006-03-16       Impact factor: 3.396

2.  Vitamin D Pretreatment Attenuates Ciprofloxacin-Induced Antibacterial Activity.

Authors:  Majed M Masadeh; Karem H Alzoubi; Bashar M Al-Taani; Majd M Masadeh; Zainah O Aburashed; Nasr Alrabadi
Journal:  Clin Pharmacol       Date:  2020-10-12

3.  Antioxidative/oxidative effects and retarding osteoconductivity of ciprofloxacin-loaded porous polyvinyl alcohol/bioactive glass hybrid.

Authors:  Salha Boulila; Hassane Oudadesse; Riadh Badraoui; Bertrand Lefeuvre; Mostafa Mabrouk; Khansa Chaabouni; Amany Mostafa; Fatma Makni-Ayedi; Allal Barroug; Tarek Rebai; Abdelfattah Elfeki; Hafed Elfeki
Journal:  Med Biol Eng Comput       Date:  2016-04-21       Impact factor: 2.602

4.  Effects of repeated oral administration of pazufloxacin mesylate and meloxicam on the antioxidant status in rabbits.

Authors:  Adil Mehraj Khan; Satyavan Rampal
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-07       Impact factor: 1.232

5.  Sub-inhibitory fosmidomycin exposures elicits oxidative stress in Salmonella enterica serovar Typhimurium LT2.

Authors:  David T Fox; Emily N Schmidt; Hongzhao Tian; Suraj Dhungana; Michael C Valentine; Nicole V Warrington; Paul D Phillips; Kellan B Finney; Emily K Cope; Jeff G Leid; Charles A Testa; Andrew T Koppisch
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

6.  Antibacterial activity of silver nanoparticles of different particle size against Vibrio Natriegens.

Authors:  Yaohua Dong; Hongling Zhu; Yuanyuan Shen; Wenting Zhang; Li Zhang
Journal:  PLoS One       Date:  2019-09-13       Impact factor: 3.240

7.  Discovery of Phloeophagus Beetles as a Source of Pseudomonas Strains That Produce Potentially New Bioactive Substances and Description of Pseudomonas bohemica sp. nov.

Authors:  Zaki Saati-Santamaría; Rubén López-Mondéjar; Alejandro Jiménez-Gómez; Alexandra Díez-Méndez; Tomáš Větrovský; José M Igual; Encarna Velázquez; Miroslav Kolarik; Raúl Rivas; Paula García-Fraile
Journal:  Front Microbiol       Date:  2018-05-08       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.